These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2129066)

  • 21. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.
    Singh P; Mishra AK; Malonia SK; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM
    J Commun Dis; 2006 Mar; 38(3):288-98. PubMed ID: 17373362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tuberculosis therapy 1990].
    Villiger B
    Schweiz Rundsch Med Prax; 1990 May; 79(21):670-4. PubMed ID: 2190295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Active drugs against Mycobacterium tuberculosis].
    Coll P
    Enferm Infecc Microbiol Clin; 2009 Oct; 27(8):474-80. PubMed ID: 19766360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
    Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
    Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antituberculosis drug resistance surveillance in Kenya, 1995.
    Githui WA; Juma ES; van Gorkom J; Kibuga D; Odhiambo J; Drobniewski F
    Int J Tuberc Lung Dis; 1998 Jun; 2(6):499-505. PubMed ID: 9626608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basic concepts in the treatment of tuberculosis.
    Swaminathan S
    Indian J Pediatr; 2002 Nov; 69 Suppl 1():S44-9. PubMed ID: 12501925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
    Kawakami K
    Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Old and new drugs for the treatment of tuberculosis in children.
    Donald PR; Schaaf HS
    Paediatr Respir Rev; 2007 Jun; 8(2):134-41. PubMed ID: 17574157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
    Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of tuberculosis infection].
    Billy C; Perronne C
    Ann Med Interne (Paris); 2002 Mar; 153(2):119-27. PubMed ID: 12037494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-resistant tuberculosis: etiology, management and prevention.
    O'Brien RJ
    Semin Respir Infect; 1994 Jun; 9(2):104-12. PubMed ID: 7973169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Controlled study comparing 3 daily chemotherapy regimens for six months in pulmonary tuberculosis in routine practice in Algiers. Results at 30 months].
    Mazouni L; Tazir M; Boulahbal F; Chaulet P
    Rev Mal Respir; 1985; 2(4):209-14. PubMed ID: 3937189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial and acquired drug resistance of Mycobacterium tuberculosis in east Delhi.
    Mahajan M; Agarwal DS; Gadre DJ; Singh NP; Gupta HC; Talwar V
    J Commun Dis; 1996 Mar; 28(1):15-9. PubMed ID: 8778175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The management of extra-pulmonary tuberculosis.
    Drug Ther Bull; 1991 Apr; 29(7):26-8. PubMed ID: 1935605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of Mycobacterium tuberculosis drug resistance in New Caledonia, 1995-1996.
    Duval P; Levenes H; Boulahbal F
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):219-23. PubMed ID: 10094323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk of acquisition of RFP resistance out of INH resistant RFP susceptible tuberculosis].
    Yoshiyama T; Ito K; Ogata H; Aono A; Wada M
    Kekkaku; 2005 Jan; 80(1):9-14. PubMed ID: 15839057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of the standard mode of chemotherapy for newly-diagnosed patients with destructive pulmonary tuberculosis with bacterial isolation].
    Mishin VIu; Chukanov VI; Vylegzhanin SV
    Probl Tuberk; 2001; (7):13-8. PubMed ID: 11763553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnosis and therapy of tuberculosis during the past 100 years.
    Mitchison DA
    Am J Respir Crit Care Med; 2005 Apr; 171(7):699-706. PubMed ID: 15709048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.